{"id":"https://openalex.org/W2005408316","doi":"https://doi.org/10.1007/s00280-013-2233-7","title":"Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab-refractory breast cancer model","display_name":"Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab-refractory breast cancer model","alternate_titles":[],"publication_year":2013,"publication_date":"2013-08-19","ids":{"openalex":"https://openalex.org/W2005408316","doi":"https://doi.org/10.1007/s00280-013-2233-7","mag":"2005408316","pmid":"https://pubmed.ncbi.nlm.nih.gov/23959459"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-013-2233-7","doi":"https://doi.org/10.1007/s00280-013-2233-7","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-013-2233-7","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005408316"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101847489","display_name":"Yuliang Sun","orcid":"https://orcid.org/0009-0002-0751-8462","observed_orcids":["https://orcid.org/0009-0002-0751-8462"]},"institutions":[{"id":"https://openalex.org/I189957204","display_name":"University of South Dakota","ror":"https://ror.org/0043h8f16","country_code":"US","type":"education","lineage":["https://openalex.org/I189957204"]},{"id":"https://openalex.org/I4210095855","display_name":"Sanford Research","ror":"https://ror.org/00sfn8y78","country_code":"US","type":"facility","lineage":["https://openalex.org/I1305840828","https://openalex.org/I4210095855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuliang Sun","raw_affiliation_strings":["Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, 2301 E 60th Street N, Sioux Falls, SD, 57104, USA","Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, Sioux Falls, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, 2301 E 60th Street N, Sioux Falls, SD, 57104, USA","institution_ids":["https://openalex.org/I189957204","https://openalex.org/I4210095855"]},{"raw_affiliation_string":"Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, Sioux Falls, USA","institution_ids":["https://openalex.org/I189957204","https://openalex.org/I4210095855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012509754","display_name":"Nandini Dey","orcid":"https://orcid.org/0000-0002-5533-8784","observed_orcids":["https://orcid.org/0000-0002-5533-8784"]},"institutions":[{"id":"https://openalex.org/I189957204","display_name":"University of South Dakota","ror":"https://ror.org/0043h8f16","country_code":"US","type":"education","lineage":["https://openalex.org/I189957204"]},{"id":"https://openalex.org/I4210095855","display_name":"Sanford Research","ror":"https://ror.org/00sfn8y78","country_code":"US","type":"facility","lineage":["https://openalex.org/I1305840828","https://openalex.org/I4210095855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nandini Dey","raw_affiliation_strings":["Department of Internal Medicine, University of South Dakota, Vermillion, SD, USA","Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, 2301 E 60th Street N, Sioux Falls, SD, 57104, USA","Department of Internal Medicine, University of South Dakota, Vermillion, USA","Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, Sioux Falls, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University of South Dakota, Vermillion, SD, USA","institution_ids":["https://openalex.org/I189957204"]},{"raw_affiliation_string":"Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, 2301 E 60th Street N, Sioux Falls, SD, 57104, USA","institution_ids":["https://openalex.org/I189957204","https://openalex.org/I4210095855"]},{"raw_affiliation_string":"Department of Internal Medicine, University of South Dakota, Vermillion, USA","institution_ids":["https://openalex.org/I189957204"]},{"raw_affiliation_string":"Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, Sioux Falls, USA","institution_ids":["https://openalex.org/I189957204","https://openalex.org/I4210095855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032187510","display_name":"Melissa G. Brammer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Brammer","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA","Genentech Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112103541","display_name":"Pradip K. De","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189957204","display_name":"University of South Dakota","ror":"https://ror.org/0043h8f16","country_code":"US","type":"education","lineage":["https://openalex.org/I189957204"]},{"id":"https://openalex.org/I4210095855","display_name":"Sanford Research","ror":"https://ror.org/00sfn8y78","country_code":"US","type":"facility","lineage":["https://openalex.org/I1305840828","https://openalex.org/I4210095855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Pradip De","raw_affiliation_strings":["Department of Internal Medicine, University of South Dakota, Vermillion, SD, USA","Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, 2301 E 60th Street N, Sioux Falls, SD, 57104, USA","Department of Internal Medicine, University of South Dakota, Vermillion, USA","Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, Sioux Falls, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University of South Dakota, Vermillion, SD, USA","institution_ids":["https://openalex.org/I189957204"]},{"raw_affiliation_string":"Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, 2301 E 60th Street N, Sioux Falls, SD, 57104, USA","institution_ids":["https://openalex.org/I189957204","https://openalex.org/I4210095855"]},{"raw_affiliation_string":"Department of Internal Medicine, University of South Dakota, Vermillion, USA","institution_ids":["https://openalex.org/I189957204"]},{"raw_affiliation_string":"Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, Sioux Falls, USA","institution_ids":["https://openalex.org/I189957204","https://openalex.org/I4210095855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068271757","display_name":"Brian R Leyland-Jones","orcid":"https://orcid.org/0000-0003-2434-0774","observed_orcids":["https://orcid.org/0000-0003-2434-0774"]},"institutions":[{"id":"https://openalex.org/I189957204","display_name":"University of South Dakota","ror":"https://ror.org/0043h8f16","country_code":"US","type":"education","lineage":["https://openalex.org/I189957204"]},{"id":"https://openalex.org/I4210095855","display_name":"Sanford Research","ror":"https://ror.org/00sfn8y78","country_code":"US","type":"facility","lineage":["https://openalex.org/I1305840828","https://openalex.org/I4210095855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brian Leyland-Jones","raw_affiliation_strings":["Department of Internal Medicine, University of South Dakota, Vermillion, SD, USA","Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, 2301 E 60th Street N, Sioux Falls, SD, 57104, USA","Department of Internal Medicine, University of South Dakota, Vermillion, USA","Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, Sioux Falls, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University of South Dakota, Vermillion, SD, USA","institution_ids":["https://openalex.org/I189957204"]},{"raw_affiliation_string":"Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, 2301 E 60th Street N, Sioux Falls, SD, 57104, USA","institution_ids":["https://openalex.org/I189957204","https://openalex.org/I4210095855"]},{"raw_affiliation_string":"Department of Internal Medicine, University of South Dakota, Vermillion, USA","institution_ids":["https://openalex.org/I189957204"]},{"raw_affiliation_string":"Edith Sanford Breast Cancer, Sanford Research/University of South Dakota, Sioux Falls, USA","institution_ids":["https://openalex.org/I189957204","https://openalex.org/I4210095855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5068271757","https://openalex.org/A5112103541"],"corresponding_institution_ids":["https://openalex.org/I189957204","https://openalex.org/I4210095855"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":1.2714,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.7798826,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"72","issue":"4","first_page":"733","last_page":"745"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9629999995231628},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9399999976158142},{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":0.859000027179718},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7820000052452087},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9639999866485596},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8769999742507935},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9210000038146973},{"id":"https://openalex.org/keywords/triple-combination-therapy","display_name":"triple combination therapy","score":0.5910000205039978},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8279317021369934},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.7833735942840576},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5233641862869263},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4227980971336365},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3950355052947998},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.383818119764328},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3190351724624634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2488289177417755},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.23811271786689758},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23314169049263},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.06336954236030579}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00280-013-2233-7","doi":"https://doi.org/10.1007/s00280-013-2233-7","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-013-2233-7","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:23959459","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23959459","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1598571431","https://openalex.org/W1964321121","https://openalex.org/W1984007340","https://openalex.org/W1989409992","https://openalex.org/W1994091018","https://openalex.org/W2005448885","https://openalex.org/W2014457594","https://openalex.org/W2026718377","https://openalex.org/W2060616543","https://openalex.org/W2104239861","https://openalex.org/W2114282952","https://openalex.org/W2115100262","https://openalex.org/W2123591186","https://openalex.org/W2124712330","https://openalex.org/W2126275851","https://openalex.org/W2139135964","https://openalex.org/W2154398220","https://openalex.org/W2157208434","https://openalex.org/W2159967578","https://openalex.org/W2163332468","https://openalex.org/W2166199281","https://openalex.org/W2166435019","https://openalex.org/W2167224460","https://openalex.org/W2210230824","https://openalex.org/W2340356457","https://openalex.org/W4290291336"],"related_works":["https://openalex.org/W2032699899","https://openalex.org/W1827534589","https://openalex.org/W2136775492","https://openalex.org/W2408289233","https://openalex.org/W2887634622","https://openalex.org/W2914195240","https://openalex.org/W2131043872","https://openalex.org/W2265171146","https://openalex.org/W3000138523","https://openalex.org/W2124748060"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005408316","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
